Patents-Review.com
ClassID:

170412 ⎘

G01N2333/52 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature from animals; from humans Assays involving cytokines

Sub-classes:
Recent Application in this class:
#1
20260115284
2026-04-30

TOXICITY MANAGEMENT FOR ANTI-TUMOR ACTIVITY OF CARS

 #2
20260079156
2026-03-19

Improved monocyte activation test

 #3
20250383360
2025-12-18

Methods of Detecting and Preventing Atopic Allergic Diseases

 #4
20250314650
2025-10-09

PHYSISORPTION OF ANTIBODIES ON FILMS

 #5
20250224400
2025-07-10

MARKERS FOR THE EARLY DETECTION OF COLON CELL PROLIFERATIVE DISORDERS

 #6
20250224392
2025-07-10

METHOD FOR EVALUATING QUALITY OF INDUCEMENT INHIBITORY-T-CELL FORMULATION

 #7
20250155451
2025-05-15

CYTOKINE PROFILING ANALYSIS

 #8
20250093368
2025-03-20

ANTIBODIES AGAINST S100A8 AND S100A9, HETERODIMER OF S100A8 AND S100A9, DETECTION KIT AND USE OF THE ANTIBODIES, HETERODIMER AND DETECTION KIT

 #9
20240368264
2024-11-07

Anti-TSLP nanobodies and their applications

 #10
20240264173
2024-08-08

METHOD OF PROGNOSIS

 #11
20240264150
2024-08-08

METHODS FOR ASSIGNING A PHENOTYPIC SIGNATURE FOR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

 #12
20240201187
2024-06-20

Method of Tracking Maintenance of Immunological Tolerance

 #13
20240173402
2024-05-30

PREDICTING OUTCOME OF TREATMENT WITH AN ANTl-alpha4beta7 INTEGRIN ANTIBODY

 #14
20240168037
2024-05-23

METHOD OF PROGNOSIS

 #15
20240133896
2024-04-25

RAPID PROCESSING AND DIRECT TESTING OF SALIVA BIOMARKERS

 #16
20240018484
2024-01-18

METHOD FOR IDENTIFYING ANTI-CANCER AGENTS USING AN IN VITRO CELL CULTURE SYSTEM THAT MAINTAINS CANCER CELL STEMNESS

 #17
20230417768
2023-12-28

METHOD FOR PROGNOSIS

 #18
20230266346
2023-08-24

METHODS FOR QUANTIFYING POTENCY OF REGENERATIVE IMMUNOTHERAPIES

 #19
20230236205
2023-07-27

METHOD AND KIT FOR THE EARLY DETECTION OF SEPSIS

 #20
20230194549
2023-06-22

METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-ASSOCIATED INFECTION IN A PATIENT

 #21
20230176058
2023-06-08

Markers for the early detection of colon cell proliferative disorders

 #22
20230105011
2023-04-06

STRATIFYING RISK OF MALIGNANCY IN INDETERMINATE THYROID NODULES AND IMMUNO-GENOMIC MARKERS FOR EARLY DETECTION OF THYROID CANCER

 #23
20230059466
2023-02-23

METHODS OF PROGNOSIS

 #24
20230013642
2023-01-19

Toxicity Management for Anti-Tumor Activity of CARs

 #25
20220381771
2022-12-01

T-CELL REACTIVITY PLATFORM

 #26
20220326256
2022-10-13

Methods of prognosis and treatment

 #27
20220317126
2022-10-06

BIOMARKERS FOR OVARIAN CANCER CTAP3-RELATED PROTEINS

 #28
20220267413
2022-08-25

Methods for the treatment of neurodegeneration

 #29
20220220559
2022-07-14

CELL-FREE MIRNA BIOMARKERS FOR PROGNOSIS AND DIAGNOSIS OF NEURODEGENERATIVE DISEASES

 #30
20220155320
2022-05-19

Cytokine profiling analysis

 #31
20220155292
2022-05-19

Multi-Analyte Molecularly Imprinted Polymer Sensor

 #32
20220082572
2022-03-17

USE OF PERIPHERAL BLOOD PRO- AND ANTI-INFLAMMATORY CYTOKINE RATIOS AS MARKERS OF IMPLANTATION PRECEDING PREGNANCY

 #33
20220074942
2022-03-10

Diagnostic for Discriminating Benign Mass From Ovarian Cancer and Application Thereof

 #34
20210396767
2021-12-23

Method for Predicting Prognosis of Ischemic Disease

 #35
20210389332
2021-12-16

GDF15 in glaucoma and methods of use thereof

 #36
20210285967
2021-09-16

A METHOD FOR DIFFERENTIALLY DIAGNOSING IN VITRO A BIPOLAR DISORDER AND A MAJOR DEPRESSIVE DISORDER

 #37
20210246203
2021-08-12

Astrotactin1-based compositions and pharmaceutical formulations

 #38
20210223267
2021-07-22

METHODS AND DEVICES FOR DETECTING DIABETIC NEPHROPATHY AND ASSOCIATED DISORDERS

 #39
20210148930
2021-05-20

Methods of Detecting and Preventing Atopic Allergic Diseases

 #40
20210115409
2021-04-22

Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemness

 #41
20210080474
2021-03-18

Methods and compositions for diagnosis and prognosis of renal injury and renal failure

 #42
20210060162
2021-03-04

Methods and compositions for the treatment of an inflammatory bowel disease

 #43
20210025895
2021-01-28

CANCER SERUM BIOMARKERS AND METHODS OF USE THEREOF

 #44
20210018504
2021-01-21

SHON AS A PROGNOSTIC BIOMARKER FOR CANCER AND AS A PREDICTOR OF RESPONSE TO ENDOCRINE THERAPY

 #45
20200363416
2020-11-19

METHODS AND KITS FOR ANALYSIS OF HMGB1 ISOFORMS

 #46
20200333329
2020-10-22

TARGETED CYTOKINE BLOCKADES FOR CAR-T THERAPY

 #47
20200330533
2020-10-22

Biomarkers and combination therapies using oncolytic virus and immunomodulation

 #48
20200309764
2020-10-01

T-cell reactivity platform

 #49
20200278352
2020-09-03

BIOMARKERS FOR PREDICTING DEGREE OF WEIGHT LOSS

 #50
20200271652
2020-08-27

Methods of prognosing early stage breast lesions

 #51
20200256878
2020-08-13

Method of treating acute coronary syndrome

 #52
20200200771
2020-06-25

GDF-15 and/or troponin T for predicting kidney failure in heart surgery patients

 #53
20200158738
2020-05-21

DIAGNOSTIC MARKERS OF COGNITIVE IMPAIRMENTS, KITS AND USES THEREOF

 #54
20200155673
2020-05-21

Predicting outcome of treatment with an anti-α4β7 integrin antibody

 #55
20200055921
2020-02-20

Methods for the treatment of neurodegeneration

 #56
20200003780
2020-01-02

METHODS OF PROGNOSIS

 #57
20190375834
2019-12-12

Disulfide-type HMGB1-specific antibody, method for measuring disulfide-type HMGB1 and kit for said measurement, and measurement method capable of quantitating all of HMGB1 molecules including reduced HMGB1, disulfide-type HMGB1 and thrombin-cleavable HMGB1 and kit for said measurement

 #58
20190271709
2019-09-05

Methods of prognosis and treatment

 #59
20190265248
2019-08-29

BIOMARKERS FOR PREDICTING DEGREE OF WEIGHT LOSS

 #60
20190248908
2019-08-15

Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)

 #61
20190233490
2019-08-01

Method of synthesizing antagonist peptides for cell growth

 #62
20190178884
2019-06-13

Intracellular osteopontin regulates the lineage commitment of lymphoid subsets

 #63
20190178872
2019-06-13

Screening assay for choice of prebiotic to prevent/treat gastrointestinal and systemic diseases

 #64
20190154701
2019-05-23

Cytokine profiling analysis

 #65
20190107544
2019-04-11

BK VIRUS SEROLOGY ASSESSMENT OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML) RISK

 #66
20190099457
2019-04-04

Immunomodulatory composition comprising bifidobacteria

 #67
20190011458
2019-01-10

GDF15 in glaucoma and methods of use thereof

 #68
20180298455
2018-10-18

RISK STRATIFICATION IN INFLUENZA

 #69
20180267058
2018-09-20

Immunological signatures and parameters predicting therapeutic responses to anti-TNF therapy

 #70
20180256712
2018-09-13

Toxicity management for anti-tumor activity of CARs

 #71
20180246098
2018-08-30

METHOD AND KIT FOR DIAGNOSING EPITHELIAL-TO-MESENCHYMAL TRANSITION (EMT) OF THE PERITONEUM

 #72
20180243411
2018-08-30

Toxicity management for anti-tumor activity of CARs

 #73
20180230435
2018-08-16

Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemness

 #74
20180228890
2018-08-16

Cross-reactive T cell epitopes of HIV, SIV, and FIV for vaccines in humans and cats

 #75
20180196054
2018-07-12

Biomarkers for ovarian cancer CTAP3-related proteins

 #76
20180188267
2018-07-05

Cardiovascular risk event prediction and uses thereof

 #77
20180164329
2018-06-14

Prostate cancer-associated secreted proteins

 #78
20180120333
2018-05-03

Diagnostic markers of cognitive impairments, kits and uses thereof

 #79
20180120331
2018-05-03

Serum biomarker panels for bipolar disorder

 #80
20180105593
2018-04-19

METHODS AND COMPOSITIONS FOR USING MHC CLASS II INVARIANT CHAIN POLYPEPTIDES AS A RECEPTOR FOR MACROPHAGE MIGRATION INHIBITORY FACTOR

 #81
20180011098
2018-01-11

METHODS AND KITS FOR ANALYSIS OF HMGB1 ISOFORMS

 #82
20170370947
2017-12-28

Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders

 #83
20170360926
2017-12-21

PREDICTING OUTCOME OF TREATMENT WITH AN ANTI-alpha4beta7 INTEGRIN ANTIBODY

 #84
20170328896
2017-11-16

ASSAY SYSTEMS FOR POINT OF CARE DETECTION OF OCULAR ANALYTES

 #85
20170248613
2017-08-31

Methods and compositions for diagnosis and prognosis of renal injury and renal failure

 #86
20170184609
2017-06-29

Human exhaled aerosol droplet biomarker system and method

 #87
20170184569
2017-06-29

Screening assay for choice of prebiotic to prevent/treat gastrointestinal and systemic diseases

 #88
20170176455
2017-06-22

Methods of detecting and preventing atopic allergic diseases

 #89
20170143758
2017-05-25

INHALATION OF NITRIC OXIDE FOR TREATING RESPIRATORY DISEASES

 #90
20170137509
2017-05-18

VACCINES AND MONOCLONAL ANTIBODIES TARGETING TRUNCATED VARIANTS OF OSTEOPONTIN AND USES THEREOF

 #91
20170128538
2017-05-11

METHODS FOR ASSESSING THE EFFICACY OF ANTI-INFLAMMATORY CYTOKINE COMPOSITIONS

 #92
20170115302
2017-04-27

Prognostic assay for success of assisted reproductive technology

 #93
20170108501
2017-04-20

Method for detecting a solid tumor cancer

 #94
20170030925
2017-02-02

Biomarkers of osteoarthritis

 #95
20170023587
2017-01-26

Prognosing mortality in patients with chronic kidney disease by detecting macrophage inhibitory cytokine-1 (MIC-1)

 #96
20170023562
2017-01-26

Apparatus for screening cells

 #97
20170010280
2017-01-12

GDF15 AS BIOMARKER FOR DIAGNOSING MITOCHONDRIAL DISEASES

 #98
20160377630
2016-12-29

METHODS TO DETERMINE THE PRESENCE OF AN ANTIBODY THAT BINDS MODIFIED HUMAN THYMIC STROMAL LYMPHOPOIETIN (TSLP)

 #99
20160334414
2016-11-17

Anti-MIF immunohistochemistry

 #100
20160326254
2016-11-10

Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)

 #101
20160317653
2016-11-03

Bacterial compositions and methods of use thereof for treatment of immune system disorders

 #102
20160243204
2016-08-25

Candidates against infection

 #103
20160210400
2016-07-21

STING crystals and modulators

 #104
20160151457
2016-06-02

Ophthalmic uses of toxin-based therapeutic peptides and pharmaceutical compositions thereof

 #105
20160139129
2016-05-19

BIOMARKERS FOR THE DIAGNOSIS AND THE RESPONSE TO TREATMENT OF PANCREATIC CANCER

 #106
20160090409
2016-03-31

Methods for the treatment of neurodegeneration

 #107
20160074478
2016-03-17

Target for diagnosis and treatment of diabetes and cardiovascular diseases

 #108
20160047795
2016-02-18

In vitro method for assessing cytokine storm responses

 #109
20160024504
2016-01-28

TREATING TH2-MEDIATED DISEASES BY INHIBITION OF BROMODOMAINS

 #110
20160018418
2016-01-21

HMGB1 and anti-HMGB1 antibodies for the prognostic of neurological disorders

 #111
20160018401
2016-01-21

METHODS OF PROGNOSIS

 #112
20160017011
2016-01-21

PHF20 AND JMJD3 COMPOSITIONS AND METHODS OF USE IN CANCER IMMUNOTHERAPY

 #113
20150377908
2015-12-31

Methods of diagnosing, treating and monitoring diabetic retinopathy

 #114
20150322538
2015-11-12

Risk stratification in influenza

 #115
20150276765
2015-10-01

Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders

 #116
20150259740
2015-09-17

PROCESSES AND KITS TO DETECT AND MONITOR FOR DIAGNOSTIC BIOMARKERS FOR POST TRAUMATIC STRESS DISORDER (PTSD) AND TO DIFFERENTIATE BETWEEN SUICIDAL AND NON-SUICIDAL FORM OF THE DISORDER

 #117
20150239972
2015-08-27

METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS

 #118
20150231230
2015-08-20

Cross-reactive T cell epitopes of HIV, SIV, and FIV for vaccines in humans and cats

 #119
20150212090
2015-07-30

Use of a panel of urinary cytokines to predict response to BCG therapy for bladder cancer

 #120
20150198601
2015-07-16

METHODS OF DIAGNOSING AND PROGNOSING COLONIC POLYPS

 #121
20150197807
2015-07-16

USE OF NANOWIRES FOR DELIVERING BIOLOGICAL EFFECTORS INTO IMMUNE CELLS

 #122
20150191729
2015-07-09

Composition comprising material for inhibiting SCF or receptor thereof for treating or preventing diseases associated with vascular permeability

 #123
20150159221
2015-06-11

CANCER PROGNOSTIC ASSAYS

 #124
20150072364
2015-03-12

Methods and kits for diagnosing osteoarthritis and predicting progression

 #125
20150064188
2015-03-05

Polypeptide structural motifs associated with cell signaling activity

 #126
20150057175
2015-02-26

Method for monitoring HIV specific T cell responses

 #127
20140377221
2014-12-25

Biomarkers and combination therapies using oncolytic virus and immunomodulation

 #128
20140370087
2014-12-18

Angiogenin for treatment of glaucoma

 #129
20140314799
2014-10-23

Methods, agents and peptides for inhibiting matrix metalloproteinase-2 signaling

 #130
20140287443
2014-09-25

Characterization of CHO-MIF gene and protein, and use thereof

 #131
20140274787
2014-09-18

Biomarker for ovarian cancer CTAP3-related proteins

 #132
20140178403
2014-06-26

Method of inhibiting binding or activity of MIF by administering a MIF antagonist

 #133
20140065602
2014-03-06

Human exhaled aerosol droplet biomarker system and method

 #134
20140011895
2014-01-09

Biomarkers for systemic lupus erythematosus

 #135
20140010778
2014-01-09

Controlling Pseudomonas aeruginosa persister cells with GM-CSF

 #136
20130303530
2013-11-14

Methods for treating chronic pelvic pain syndrome

 #137
20130280311
2013-10-24

Use of VEGF-C agonists for inhibiting ultraviolet B-induced skin damage

 #138
20130266967
2013-10-10

Function homology screening

 #139
20130252267
2013-09-26

Method of detecting a urine protein fragment and a serum protein fragment

 #140
20130195761
2013-08-01

Methods and compositions for diagnosing Alzheimer's disease and age-related macular degeneration

 #141
20130065221
2013-03-14

HMGB1 and anti-HMGB1 antibodies for the prognostic of neurological disorders

 #142
20130039930
2013-02-14

BIOMARKER FOR SENSITIVITY TO THERAPY WITH A NOTCH INHIBITOR

 #143
20130023647
2013-01-24

Modified human thymic stromal lymphopoietin

 #144
20130005836
2013-01-03

Compositions and methods related to S100A12

 #145
20120328567
2012-12-27

BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO IFNB AND USES THEREOF

 #146
20120309697
2012-12-06

METHODS OF DIAGNOSING AND PROGNOSING COLONIC POLYPS

 #147
20120309671
2012-12-06

PROCESS FOR THE MEASUREMENT OF THE POTENCY OF GLATIRAMER ACETATE

 #148
20120294870
2012-11-22

Compositions and methods for diagnosis and treatment of tumors

 #149
20120252035
2012-10-04

GDF-15 and/or Troponin T for Predicting Kidney Failure in Heart Surgery Patients

 #150
20120214683
2012-08-23

METHODS OF TARGETING BAFF

 #151
20120208772
2012-08-16

Cytokine zalpha11 ligand

 #152
20120183976
2012-07-19

METHODS OF ASSESSING ACTIVITY OF A POLYSACCHARIDE COMPOSITION

 #153
20120178682
2012-07-12

GB1 Peptidic Compounds and Methods for Making and Using the Same

 #154
20120178100
2012-07-12

Serum Markers Predicting Clinical Response to Anti-TNF Alpha Antibodies in Patients with Psoriatic Arthritis

 #155
20120172356
2012-07-05

SERUM BIOMARKERS FOR CHAGAS DISEASE

 #156
20120116181
2012-05-10

BLOOD PROTEIN MARKERS IN METHODS AND APPARATUSES TO AID DIAGNOSIS AND MANAGEMENT OF SLEEP DISORDERED BREATHING

 #157
20120114596
2012-05-10

TSLP PROMOTES IMMUNE EVASION AND PERSISTENCE OF VIRUSES

 #158
20120107420
2012-05-03

METHODS OF PROGNOSIS IN CHRONIC KIDNEY DISEASE

 #159
20120094305
2012-04-19

Methods for treating and diagnosing fibrotic and fibroproliferative diseases

 #160
20120077685
2012-03-29

INTRATUMORAL GENE EXPRESSION LEVELS OF TP AND VEGF ARE ASSOCIATED WITH CLINICAL OUTCOMES IN RECTAL CANCER PATIENTS TREATED WITH 5-FLUOROURACIL AND PELVIC RADIATION

 #161
20120071340
2012-03-22

BIOMARKERS

 #162
20120065094
2012-03-15

Methods and kits for diagnosing osteoarthritis and predicting progression

 #163
20120045432
2012-02-23

B LYMPHOCYTE STIMULATOR ASSAYS

 #164
20120039914
2012-02-16

MIF antagonists

 #165
20120039890
2012-02-16

Methods of treatment using antibodies to Neutrokine-alpha

 #166
20120021414
2012-01-26

Method of assaying an individual for immune impairment

 #167
20120010234
2012-01-12

Use of VEGF-D in the diagnosis of lymphangioleiomyomatosis (LAM) disease

 #168
20120010138
2012-01-12

NOVEL USES OF VEGFXXXB

 #169
20120010094
2012-01-12

DETECTING AND MONITORING LEFT VENTRICULAR HYPERTROPHY AND CONGESTIVE HEART FAILURE BY PROFILING BIOMARKERS

 #170
20120004185
2012-01-05

POLYPEPTIDE STRUCTURAL MOTIFS ASSOCIATED WITH CELL SIGNALING ACTIVITY

 #171
20110312000
2011-12-22

Monoclonal antibody and use thereof

 #172
20110294678
2011-12-01

Cells screening method

 #173
20110263443
2011-10-27

DIFFERENTIATING BETWEEN FIBROSIS AND CIRRHOSIS

 #174
20110250623
2011-10-13

Biomarker and method for detecting a chronic inflammatory-associated disease

 #175
20110230637
2011-09-22

MODIFIED HUMAN THYMIC STROMAL LYMPHOPOIETIN

 #176
20110218116
2011-09-08

BIOMARKERS OF OSTEOARTHRITIS

 #177
20110212472
2011-09-01

Asbestos Exposure, Pleural Mesothelioma and Osteopontin Levels

 #178
20110195971
2011-08-11

Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof

 #179
20110195901
2011-08-11

ARTERY- AND VEIN-SPECIFIC PROTEINS AND USES THEREFOR

 #180
20110189706
2011-08-04

Process for the measurement of the potency of glatiramer acetate

 #181
20110177959
2011-07-21

Methods and Devices for Detecting Kidney Transplant Rejection

 #182
20110177538
2011-07-21

BIOMARKERS FOR RHEUMATOID ARTHRITIS (RA)

 #183
20110165160
2011-07-07

NEUTROKINE-ALPHA AND NEUTROKINE-ALPHA SPLICE VARIANT

 #184
20110152117
2011-06-23

Methods of determining efficacy of treatments of diseases of the bowel

 #185
20110151470
2011-06-23

BIOMARKERS FOR ASSESSING RESPONSE TO C-MET TREATMENT

 #186
20110150877
2011-06-23

EPHRIN-B RECEPTOR PROTEIN INVOLVED IN CARCINOMA

 #187
20110136153
2011-06-09

Use of VEGF-D in the diagnosis of lymphangioleiomyomatosis (LAM) disease

 #188
20110135639
2011-06-09

B LYMPHOCYTE STIMULATOR ASSAYS

 #189
20110123455
2011-05-26

RATIONAL DESIGN OF REGENERATIVE MEDICINE PRODUCTS

 #190
20110086371
2011-04-14

URINE AND SERUM BIOMARKERS ASSOCIATED WITH DIABETIC NEPHROPATHY

 #191
20110079077
2011-04-07

Urine and serum biomarkers associated with diabetic nephropathy

 #192
20110065608
2011-03-17

Devices for Detecting Renal Disorders

 #193
20110065599
2011-03-17

Methods and Devices for Detecting Kidney Damage

 #194
20110065598
2011-03-17

Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders

 #195
20110065593
2011-03-17

Computer Methods and Devices for Detecting Kidney Damage

 #196
20110065137
2011-03-17

Methods and devices for detecting obstructive uropathy and associated disorders

 #197
20110065136
2011-03-17

Methods and Devices for Detecting Glomerulonephritis and Associated Disorders

 #198
20110053203
2011-03-03

Copolymer assay

 #199
20110052590
2011-03-03

NEUTROKINE-ALPHA ANTIBODIES AND METHODS OF USE THEREOF

 #200
20110046042
2011-02-24

Long Interspersed Nuclear Element Polypeptide Compositions and Methods of Use Thereof

 #201
20110039284
2011-02-17

METHODS OF PROGNOSIS

 #202
20110033857
2011-02-10

Peptide sequence that promotes tumor invasion

 #203
20110028349
2011-02-03

Endothelial monocyte activation polypeptide II, a biomarker for use in diagnosis and treatment of brain injury

 #204
20110020321
2011-01-27

Method of inhibiting binding or activity of MIF by administering a MIF antagonist

 #205
20110014205
2011-01-20

Methods for treating chronic pelvic pain syndrome with antibodies that binds MCP-1 or MIP-1A

 #206
20110008328
2011-01-13

METHOD FOR CONTROLLING GLUCOSE UPTAKE AND INSULIN SENSITIVITY

 #207
20100330073
2010-12-30

METHODS OF TREATMENT USING ANTIBODIES TO NEUTROKINE-ALPHA

 #208
20100322950
2010-12-23

Compositions and methods for diagnosis and treatment of tumors

 #209
20100311758
2010-12-09

METHOD FOR DIAGNOSIS OF INFLAMMATORY DISEASES USING CALGRANULIN C

 #210
20100297064
2010-11-25

Cytokine zalpha11 ligand antibodies

 #211
20100297063
2010-11-25

CYTOKINE ZALPHA11 LIGAND ANTIBODIES

 #212
20100266707
2010-10-21

METHOD OF TREATING CACHEXIA WITH THE REMOVAL OR INACTIVATION OF MACROPHAGE INHIBITORY CYTOKINE-1

 #213
20100261210
2010-10-14

Compositions and methods for diagnosing and treating prostate cancer

 #214
20100261194
2010-10-14

NEUTROKINE-ALPHA ANTIBODIES AND METHODS OF USE THEREOF

 #215
20100255467
2010-10-07

ASSAYS FOR DETERMINING EXPOSURE TO MULTIWALLED CARBON NANOTUBES

 #216
20100242126
2010-09-23

Regulator of ephrin-Eph receptor signaling and mouse having abnormal ephrin-Eph receptor signaling mechanisms

 #217
20100234407
2010-09-16

PREVENTIVES/REMEDIES FOR MYELOMA TUMOR AND METHOD FOR DIAGNOSING THE SAME

 #218
20100222557
2010-09-02

Cytokine zalpha11 ligand antibodies

 #219
20100197033
2010-08-05

Urine and serum biomarkers associated with diabetic nephropathy

 #220
20100196360
2010-08-05

NEUTROKINE-ALPHA AND NEUTROKINE-ALPHA SPLICE VARIANT

 #221
20100184026
2010-07-22

Companion Diagnostic Assays For Endothelin Receptor Antagonists

 #222
20100167393
2010-07-01

Nucleic acid encoding modified human thymic stromal lymphopoietin

 #223
20100151492
2010-06-17

Methods for the treatment of infections and tumors

 #224
20100130419
2010-05-27

Artery- and vein-specific proteins and uses therefor

 #225
20100111939
2010-05-06

Monoclonal antibody and use thereof

 #226
20100099600
2010-04-22

Candidates against infection

 #227
20100099106
2010-04-22

Cell death inhibitor

 #228
20100093007
2010-04-15

Method of Diagnosis of Tuberculosis Related Immune Restoration Syndrome (IRS)

 #229
20100092977
2010-04-15

IRF-5 haplotypes in systemic lupus erythematosus

 #230
20100075342
2010-03-25

Biomarker for ovarian cancer CTAP3-related proteins

 #231
20100074887
2010-03-25

Methods for treating and diagnosing fibrotic and fibroproliferative diseases

 #232
20100035294
2010-02-11

SYSTEM TO ASSESS THE BIOLOGICAL ACTIVITY OF CHEMOATTRACTANTS

 #233
20100021950
2010-01-28

SCREENING METHOD FOR ANTI-DIABETIC COMPOUNDS

 #234
20100015132
2010-01-21

Uses of mammalian cytokines and agonists; related reagents

 #235
20090325188
2009-12-31

Method for detecting IL-16 activity and modulation of IL-16 activity based on rantes proxy protein levels

 #236
20090274696
2009-11-05

METHODS FOR TREATING INFLAMMATION

 #237
20090263828
2009-10-22

Novel assay for precursor T-cells having high proliferative capacity (PHPC-asay)

 #238
20090263404
2009-10-22

Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor

 #239
20090263399
2009-10-22

Method for establishing the sensitivity of tumours to capecitabin and test kit

 #240
20090253588
2009-10-08

Differentiating ES cells using a tenascin

 #241
20090215071
2009-08-27

METHODS OF TARGETING BAFF

 #242
20090186375
2009-07-23

Method for Determining Bioactivity of Molecules

 #243
20090170866
2009-07-02

Moesin, caveolin 1 and yes associated protein 1 as predictive markers of response to dasatinib in breast cancers

 #244
20090169565
2009-07-02

Neutrokine-alpha antibodies and methods of use thereof

 #245
20090156506
2009-06-18

Use of VEGF-D in the diagnosis of lymphangioleiomyomatosis (LAM) disease

 #246
20090136524
2009-05-28

Compositions and methods for diagnosis and treatment of tumors

 #247
20090104189
2009-04-23

NEUTROKINE-ALPHA AND NEUTROKINE-ALPHA SPLICE VARIANT

 #248
20090075312
2009-03-19

ASSESSING COLORECTAL CANCER BY MEASURING OSTEOPONTIN AND CARCINOEMBRYONIC ANTIGEN

 #249
20090074712
2009-03-19

Methods for Treatment and Prevention of Infection

 #250
20090068691
2009-03-12

Endothelial-monocyte activating polypeptide II, a biomarker for use in diagnosis of brain injury

 #251
20090068201
2009-03-12

Methods of treatment using antibodies to neutrokine-alpha

 #252
20090061436
2009-03-05

Peptide sequence that promotes tumor invasion

 #253
20090053253
2009-02-26

Process for the measurement of the potency of glatiramer acetate

 #254
20090048117
2009-02-19

MODULATION OF IMMUNE SYSTEM FUNCTION BY MODULATION OF POLYPEPTIDE ARGININE METHYLTRANSFERASES

 #255
20090041787
2009-02-12

Chemokine receptor antagonists as therapeutic agents

 #256
20090035301
2009-02-05

METHODS FOR DIAGNOSING AND TREATING BLADDER CANCER

 #257
20080279813
2008-11-13

Cd4+ Cd25+ T-cells activated to a specific antigen

 #258
20080274109
2008-11-06

Myeloid progenitor inhibitory factor-1 (MPIF-1) polypeptides

 #259
20080268478
2008-10-30

Use of Eotaxin as a Diagnostic Indicator For Atherosclerosis and Vascular Inflammation

 #260
20080255766
2008-10-16

Methods and kits for the diagnosis of sickle cell

 #261
20080206794
2008-08-28

Systems And Methods For Characterizing Contrast Induced-Nephropathy

 #262
20080153172
2008-06-26

Method for the diagnosis of chronic stress and related disorders

 #263
20080146507
2008-06-19

Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor

 #264
20080145866
2008-06-19

Modified human thymic stromal lymphopoietin

 #265
20080096208
2008-04-24

BIOMARKERS FOR ASSESSING RESPONSE TO C-MET TREATMENT

 #266
20080070271
2008-03-20

FUNCTION HOMOLOGY SCREENING

 #267
20080064056
2008-03-13

FUNCTION HOMOLOGY SCREENING

 #268
20080050832
2008-02-28

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND/OR PROGNOSIS IN SYSTEMIC INFLAMMATORY RESPONSE SYNDROMES

 #269
20080026386
2008-01-31

IRF-5 HAPLOTYPES IN SYSTEMIC LUPUS ERYTHEMATOSUS

 #270
20080019973
2008-01-24

Methods for Treating Ocular Inflammation by Neutralizing Cxcl10 Activity

 #271
20070299005
2007-12-27

Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof

 #272
20070274995
2007-11-29

CARDIOTROPHIN-1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR

 #273
20070224137
2007-09-27

Methods of reducing skin damage and edema

 #274
20070218523
2007-09-20

Modified human thymic stromal lymphopoietin

 #275
20070190582
2007-08-16

Platelet surface PF4 antigenic complexes as a diagnostic indicator in heparin-induced thrombocytopenia

 #276
20070172902
2007-07-26

Biomarker for ovarian cancer

 #277
20070166794
2007-07-19

Cytokine zalpha11 ligand fusion proteins

 #278
20070160618
2007-07-12

CARDIOTROPHIN-1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR

 #279
20070142281
2007-06-21

Preventives/remedies for myeloma tumor and method for diagnosing the same

 #280
20070128303
2007-06-07

Anti-inflammatory, cytoprotective factor derivable from a probiotic organism

 #281
20070099269
2007-05-03

CYTOKINE ZALPHA11 LIGAND

 #282
20070098683
2007-05-03

CYTOKINE ZALPHA11 LIGAND ANTIBODIES

 #283
20070098682
2007-05-03

CYTOKINE ZALPHA11 LIGAND ANTIBODIES

 #284
20070082371
2007-04-12

FAMILY OF GENES ENCODING APOPTOSIS-RELATED PEPTIDES, PEPTIDES ENCODED THEREBY AND METHODS OF USE THEREOF

 #285
20070077585
2007-04-05

Compositions and methods for IL-13 biomarkers

 #286
20070077574
2007-04-05

Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof

 #287
20070071751
2007-03-29

FAMILY OF GENES ENCODING APOPTOSIS-RELATED PEPTIDES, PEPTIDES ENCODED THEREBY AND METHODS OF USE THEREOF

 #288
20070066808
2007-03-22

Cytokine zalpha11 ligand fusion proteins

 #289
20070066807
2007-03-22

Cytokine zalpha11 ligand fusion proteins

 #290
20070059825
2007-03-15

Method for expanding hematopoietic cells using cytokine zalpha11 ligand

 #291
20070054320
2007-03-08

Cytokine zalpha11 ligand antibodies and methods of use

 #292
20070049529
2007-03-01

Methods of using cytokine zalpha11 ligand

 #293
20070048845
2007-03-01

CYTOKINE ZALPHA11 LIGAND FUSION PROTEINS

 #294
20070048260
2007-03-01

Cytokine zalpha11 ligand fusion proteins

 #295
20070048259
2007-03-01

Method of use of cytokine ZALPHA11 ligand

 #296
20070041974
2007-02-22

CYTOKINE ZALPHA11 LIGAND ANTIBODIES

 #297
20070036781
2007-02-15

Method for detection of MIP-4 and CCRL2 binding and activity modulating agents

 #298
20070014800
2007-01-18

Cytokine zalpha11 ligand antibodies

 #299
20060292648
2006-12-28

Method of screening for inhibitors of osteopontin

 #300
20060288434
2006-12-21

Artery-and vein-specific proteins and uses therefor